The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Autoantibodies (AA) against the EGF/EGFR and VEGFA/VEGFR1 as prognosticator in epithelial ovarian cancer (EOC) patients.
Elena Ioana Braicu
No relevant relationships to disclose
Ralf Dechend
No relevant relationships to disclose
Duska Dragun
No relevant relationships to disclose
Andreas Busjahn
No relevant relationships to disclose
Rolf Wachter
No relevant relationships to disclose
Gabriela Riemekasten
No relevant relationships to disclose
Michaela Golic
No relevant relationships to disclose
Harald Heidecke
No relevant relationships to disclose
Marc Kuhberg
No relevant relationships to disclose
Dominik N Mueller
No relevant relationships to disclose
Jalid Sehouli
No relevant relationships to disclose